Literature DB >> 21127042

Role of DeltaNp63gamma in epithelial to mesenchymal transition.

Jaime Lindsay1, Simon S McDade, Adam Pickard, Karen D McCloskey, Dennis J McCance.   

Abstract

Although members of the p63 family of transcription factors are known for their role in the development and differentiation of epithelial surfaces, their function in cancer is less clear. Here, we show that depletion of the ΔNp63α and β isoforms, leaving only ΔNp63γ, results in epithelial to mesenchymal transition (EMT) in the normal breast cell line MCF10A. EMT can be rescued by the expression of the ΔNp63α isoform. We also show that ΔNp63γ expressed in a background where all the other ΔNp63 are knocked down causes EMT with an increase in TGFβ-1, -2, and -3 and downstream effectors Smads2/3/4. In addition, a p63 binding site in intron 1 of TGFβ was identified. Inhibition of the TGFβ response with a specific inhibitor results in reversion of EMT in ΔNp63α- and β-depleted cells. In summary, we show that p63 is involved in inhibiting EMT and reduction of certain p63 isoforms may be important in the development of epithelial cancers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21127042      PMCID: PMC3030392          DOI: 10.1074/jbc.M110.162511

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.

Authors:  Pamela Ghioni; Fabrizio Bolognese; Pascal H G Duijf; Hans Van Bokhoven; Roberto Mantovani; Luisa Guerrini
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

2.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

3.  Differential expression of p63 isoforms in normal tissues and neoplastic cells.

Authors:  Karin Nylander; Borek Vojtesek; Rudolf Nenutil; Britta Lindgren; Göran Roos; Wang Zhanxiang; Björn Sjöström; Ake Dahlqvist; Philip J Coates
Journal:  J Pathol       Date:  2002-12       Impact factor: 7.996

4.  Frequent alteration of p63 expression in human primary bladder carcinomas.

Authors:  B J Park; S J Lee; J I Kim; S J Lee; C H Lee; S G Chang; J H Park; S G Chi
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

5.  Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma.

Authors:  Michael Herfs; Pascale Hubert; Meggy Suarez-Carmona; Anca Reschner; Sven Saussez; Geert Berx; Pierre Savagner; Jacques Boniver; Philippe Delvenne
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

6.  A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism.

Authors:  Zach Serber; Helen C Lai; Annie Yang; Horng D Ou; Martina S Sigal; Alexander E Kelly; Beatrice D Darimont; Pascal H G Duijf; Hans Van Bokhoven; Frank McKeon; Volker Dötsch
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

7.  Loss of p63 expression is associated with tumor progression in bladder cancer.

Authors:  Marshall J Urist; Charles J Di Como; Ming-Lan Lu; Elizabeth Charytonowicz; David Verbel; Christopher P Crum; Tan A Ince; Frank D McKeon; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

8.  p63 expression in normal, hyperplastic and malignant breast tissues.

Authors:  Xiaojuan Wang; Ichiro Mori; Weihua Tang; Misa Nakamura; Yasushi Nakamura; Misako Sato; Takeo Sakurai; Kennichi Kakudo
Journal:  Breast Cancer       Date:  2002       Impact factor: 4.239

9.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

Authors:  Gareth J Inman; Francisco J Nicolás; James F Callahan; John D Harling; Laramie M Gaster; Alastair D Reith; Nicholas J Laping; Caroline S Hill
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

10.  Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51.

Authors:  M Senoo; I Tsuchiya; Y Matsumura; T Mori; Y Saito; H Kato; T Okamoto; S Habu
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

View more
  34 in total

1.  DeltaNp63α protein triggers epithelial-mesenchymal transition and confers stem cell properties in normal human keratinocytes.

Authors:  Ju-Eun Oh; Reuben H Kim; Ki-Hyuk Shin; No-Hee Park; Mo K Kang
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

2.  Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.

Authors:  Ivette Valencia-Sama; Yulei Zhao; Dulcie Lai; Helena J Janse van Rensburg; Yawei Hao; Xiaolong Yang
Journal:  J Biol Chem       Date:  2015-05-20       Impact factor: 5.157

3.  Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells.

Authors:  Kathryn E Yoh; Kausik Regunath; Asja Guzman; Seung-Min Lee; Neil T Pfister; Olutosin Akanni; Laura J Kaufman; Carol Prives; Ron Prywes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-28       Impact factor: 11.205

4.  p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer.

Authors:  C Lodillinsky; E Infante; A Guichard; R Chaligné; L Fuhrmann; J Cyrta; M Irondelle; E Lagoutte; S Vacher; H Bonsang-Kitzis; M Glukhova; F Reyal; I Bièche; A Vincent-Salomon; P Chavrier
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

5.  Transcription factor p63 regulates key genes and wound repair in human airway epithelial basal cells.

Authors:  Stephanie M B Warner; Tillie-Louise Hackett; Furquan Shaheen; Teal S Hallstrand; Anthony Kicic; Stephen M Stick; Darryl A Knight
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

6.  P63 regulates tubular formation via epithelial-to-mesenchymal transition.

Authors:  Y Zhang; W Yan; X Chen
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

7.  ΔNp63γ/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers.

Authors:  Simon S McDade; Dennis J McCance; Kirtiman Srivastava; Adam Pickard; Stephanie G Craig; Gerard P Quinn; Shauna M Lambe; Jacqueline A James
Journal:  Clin Cancer Res       Date:  2018-05-08       Impact factor: 12.531

8.  ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxis.

Authors:  Andrew J DeCastro; Pratima Cherukuri; Amanda Balboni; James DiRenzo
Journal:  Mol Cancer Ther       Date:  2014-11-05       Impact factor: 6.261

9.  15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.

Authors:  Dongdong Lu; Chang Han; Tong Wu
Journal:  J Biol Chem       Date:  2013-05-16       Impact factor: 5.157

10.  Epstein-Barr virus latent membrane protein 2 effects on epithelial acinus development reveal distinct requirements for the PY and YEEA motifs.

Authors:  Julie A Fotheringham; Nancy Raab-Traub
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.